BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 27192519)

  • 1. Leprosy among children under 15 years of age: literature review.
    Oliveira MB; Diniz LM
    An Bras Dermatol; 2016 Apr; 91(2):196-203. PubMed ID: 27192519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leprosy: a review of laboratory and therapeutic aspects--part 2.
    Lastória JC; Abreu MA
    An Bras Dermatol; 2014; 89(3):389-401. PubMed ID: 24937811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Characteristics of leprosy reactions in paucibacillary and multibacillary individuals attended at two reference centers in Recife, Pernambuco].
    Teixeira MA; Silveira VM; França ER
    Rev Soc Bras Med Trop; 2010; 43(3):287-92. PubMed ID: 20563498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding the type 1 reactional state for early diagnosis and treatment: a way to avoid disability in leprosy.
    Nery JA; Bernardes Filho F; Quintanilha J; Machado AM; Oliveira Sde S; Sales AM
    An Bras Dermatol; 2013; 88(5):787-92. PubMed ID: 24173185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multi-centre study on quality of routine data collection on relapses.
    Deepak S; Gazzoli G
    Lepr Rev; 2012 Dec; 83(4):340-3. PubMed ID: 23614251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiological situation of leprosy in Salvador from 2001 to 2009.
    Moreira SC; Batos CJ; Tawil L
    An Bras Dermatol; 2014; 89(1):107-17. PubMed ID: 24626655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leprosy Reactions in Patients Coinfected with HIV: Clinical Aspects and Outcomes in Two Comparative Cohorts in the Amazon Region, Brazil.
    Pires CA; Jucá Neto FO; de Albuquerque NC; Macedo GM; Batista Kde N; Xavier MB
    PLoS Negl Trop Dis; 2015; 9(6):e0003818. PubMed ID: 26029928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Description of leprosy classification at baseline among patients enrolled at the uniform multidrug therapy clinical trial for leprosy patients in Brazil.
    Moura RS; Penna GO; Cardoso LP; de Andrade Pontes MA; Cruz R; de Sá Gonçalves H; Fernandes Penna ML; de Araújo Stefani MM; Bührer-Sékula S
    Am J Trop Med Hyg; 2015 Jun; 92(6):1280-4. PubMed ID: 25940192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical manifestations of leprosy after BCG vaccination: an observational study in Bangladesh.
    Richardus RA; Butlin CR; Alam K; Kundu K; Geluk A; Richardus JH
    Vaccine; 2015 Mar; 33(13):1562-7. PubMed ID: 25701674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. World Health Organization (WHO) antibiotic regimen against other regimens for the treatment of leprosy: a systematic review and meta-analysis.
    Lazo-Porras M; Prutsky GJ; Barrionuevo P; Tapia JC; Ugarte-Gil C; Ponce OJ; Acuña-Villaorduña A; Domecq JP; De la Cruz-Luque C; Prokop LJ; Málaga G
    BMC Infect Dis; 2020 Jan; 20(1):62. PubMed ID: 31959113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TH17 cells, interleukin-17 and interferon-γ in patients and households contacts of leprosy with multibacillary and paucibacillary forms before and after the start of chemotherapy treatment.
    de Almeida-Neto FB; Assis Costa VM; Oliveira-Filho AF; de Souza Franco E; Tavares Julião de Lima EV; Barros de Lorena VM; Oliveira de Souza VM; de Sousa Maia MB
    J Eur Acad Dermatol Venereol; 2015 Jul; 29(7):1354-61. PubMed ID: 25429820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A clinical trial for uniform multidrug therapy for leprosy patients in Brazil: rationale and design.
    Penna GO; Pontes MA; Cruz R; Gonçalves Hde S; Penna ML; Bührer-Sékula S
    Mem Inst Oswaldo Cruz; 2012 Dec; 107 Suppl 1():22-7. PubMed ID: 23283449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors associated with anti-phenolic glycolipid-I seropositivity among the household contacts of leprosy cases.
    Carvalho AP; da Conceição Oliveira Coelho Fabri A; Corrêa Oliveira R; Lana FC
    BMC Infect Dis; 2015 May; 15():219. PubMed ID: 26024906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leprosy: down but not out.
    Sachdeva S; Khan Z; Ansari MA; Amin SS
    Trop Doct; 2011 Jan; 41(1):28-30. PubMed ID: 21088022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Borderline tuberculoid leprosy in childhood onset systemic lupus erythematosus patient.
    Lopes VA; Lourenço DM; Guariento A; Trindade MA; Avancini J; Silva CA
    Lupus; 2015 Nov; 24(13):1448-51. PubMed ID: 26113359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiological, clinical, and operational aspects of leprosy patients assisted at a referral service in the state of Maranhão, Brazil.
    Corrêa Rda G; Aquino DM; Caldas Ade J; Amaral DK; França FS; Mesquita ER
    Rev Soc Bras Med Trop; 2012 Feb; 45(1):89-94. PubMed ID: 22370835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Childhood leprosy in a tertiary-care hospital in Delhi, India: a reappraisal in the post-elimination era.
    Singal A; Sonthalia S; Pandhi D
    Lepr Rev; 2011 Sep; 82(3):259-69. PubMed ID: 22125934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Observations in 11 patients with leprosy and human immunodeficiency virus co-association.
    Pai VV; Tayshetye PU; Ganapati R
    Indian J Dermatol Venereol Leprol; 2011; 77(6):714-6. PubMed ID: 22016284
    [No Abstract]   [Full Text] [Related]  

  • 19. Leprosy: clinical and epidemiological study in patients above 60 years in Espírito Santo State - Brazil.
    Diniz LM; Maciel LB
    An Bras Dermatol; 2018; 93(6):824-828. PubMed ID: 30484526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leprosy beyond MDT: study of follow-up of 100 released from treatment cases.
    Vara N; Agrawal M; Marfatia Y
    Indian J Lepr; 2010; 82(4):189-94. PubMed ID: 21434595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.